• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: REVISION OPTICS RAINDROP NEAR VISION INLAY; CORNEAL INLAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

REVISION OPTICS RAINDROP NEAR VISION INLAY; CORNEAL INLAY Back to Search Results
Model Number PP6-530-0027-US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Corneal Clouding/Hazing (1878); Loss of Vision (2139)
Event Type  Injury  
Manufacturer Narrative
The explanted inlay was returned to the manufacturer and subjected to visual microscopic inspection and dimensional analysis.The damage observed on the inlay is consistent with findings for corneal inlays that have been explanted.The edge thickness and diameter were measured and found to be within specifications.The device history record (dhr) review of the manufacturing lot for this device was performed and there were no discrepancies or unusual findings related to the reported issue.Corneal haze and inlay removal are listed in the device labeling as known potential risks.Complaint reference number: (b)(4).
 
Event Description
The subject was enrolled in the clinical study for ide #(b)(6) and underwent surgery with implantation of the investigational corneal inlay.Postoperatively, the patient presented with recurrent corneal haze and the inlay was subsequently explanted.Additional information has been requested.
 
Manufacturer Narrative
(b)(4).
 
Event Description
Additional information was requested from the study investigator, who provided the following additional event details.The subject underwent inlay implantation in the right eye on (b)(6) 2013.During surgery, the targeted flap depth was 170 microns, however, the actual flap depth was only 149 microns.There were numerous recurrences of corneal haze throughout the course of the study and beyond.The haze was characterized as trace peripheral edge haze and i+ central haze.The patient's best corrected distance visual acuity (bcdva) decreased from 20/20 (preoperatively) to 20/40 at onset and 20/32 immediately prior to explantation of the inlay on (b)(6) 2016.At last examination on (b)(6) 2017, bcdva had improved to 20/25 and the patient is doing well and corneal haze improved to trace.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAINDROP NEAR VISION INLAY
Type of Device
CORNEAL INLAY
Manufacturer (Section D)
REVISION OPTICS
25651 atlantic ocean dr.,
ste. a1
lake forest CA 92630 8835
Manufacturer (Section G)
REVISION OPTICS
25651 atlantic ocean dr.,
ste. a1
lake forest CA 92630 8835
Manufacturer Contact
pushpita singh
25651 atlantic ocean dr.,
ste. a1
lake forest, CA 92630-8835
9497072740
MDR Report Key6603337
MDR Text Key76375477
Report Number3005956347-2017-00047
Device Sequence Number1
Product Code LQE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
G090149
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/31/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date05/01/2014
Device Model NumberPP6-530-0027-US
Device Lot Number002455
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/26/2016
Is the Reporter a Health Professional? No
Date Manufacturer Received06/02/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/21/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age63 YR
-
-